Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Sorrento Therapeutics Inc banner

Sorrento Therapeutics Inc
OTC:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
OTC:SRNE
Watchlist
Price: 0.0016 USD -36%
Market Cap: $882k
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SRNE Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for SRNE.
SRNE Lowest Forecast
Wall Street Target
Not Available
SRNE Average Forecast
Wall Street Target
Not Available
SRNE Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sorrento Therapeutics Inc Competitors:
Price Targets
WINA
Winmark Corp
20% Upside
FBIZ
First Business Financial Services Inc
20% Upside
PTCT
PTC Therapeutics Inc
28% Upside
WINA
Winmark Corp
20% Upside
FBIZ
First Business Financial Services Inc
20% Upside
PTCT
PTC Therapeutics Inc
28% Upside

Revenue
Forecast

N/A
Past Growth
88% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
88% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

The compound annual growth rate of Sorrento Therapeutics Inc's revenue for the next 3 years is 88%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss

What are analyst estimates?

See Also

Summary
SRNE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRNE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRNE stock valuation using valuation multiples.
Wall Street Estimates
SRNE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRNE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRNE's stock price target?
Not Available

SRNE doesn't have any price targets made by Wall Street professionals.

What is Sorrento Therapeutics Inc's Revenue forecast?
Projected CAGR
88%

The compound annual growth rate of Sorrento Therapeutics Inc's revenue for the next 3 years is 88%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.